Aurinia Pharmaceuticals Inc (AUPH)

[Jesspro]

Kindzal, While waiting for the p3 results is the best option, it will take time before it happens plus Glickman doesn’t have a choice if the tutes or big shareholders want it sold. When we talk about discount, it may be reasonable enough profit for the big shareholders to okay the bid. It is a win win scenario for the longs here
as most of us have a small cost basis on this stock. While it is being speculated that p3 would be a breeze because of its design, selling it early is a sure profit for us as we don’t have to wait whether p3 trial is a success.
Or not. Something could go wrong along the p3 trial. It’s not a 100% sure thing.